Microbiome and fragmentation pattern of blood cell-free DNA and fecal metagenome enhance colorectal cancer micro-dysbiosis and diagnosis analysis: a proof-of-concept study
mSystems · 2025
DOI: 10.1128/msystems.00276-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Zhongkun Zhou und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Feces, Metagenome, Dysbiosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu Provincial Science and Technology Major Project, The Lanzhou Municipal Science and Technology Program, The College Students' Innovation and Entrepreneurship Program of Lanzhou University, China.
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third most common cancer, and it can be prevented by performing early screening. As a hallmark of cancer, the human microbiome plays important roles in the occurrence and development of CRC. Recently, the blood microbiome has been proposed as an effective diagnostic tool for various diseases, yet its performance on CRC deserves further exploration. In this study, 133 human feces and 120 blood samples are collected, including healthy individuals, adenoma patients, and CRC patients. The blood cfDNA and fecal genome are subjected to shotgun metagenome sequencing. After removing human sequences, the microbial sequences in blood are analyzed. Based on the differential microbes and functions, random forest (RF) models are constructed for adenoma and CRC diagnosis. The results show that alterations of blood microbial signatures can be captured under low coverage (even at 3×). RF diagnostic models based on blood microbial markers achieve high area under the curve (AUC) values for adenoma patients (0.8849) and CRC patients (0.9824). When the fragmentation pattern is combined with microbial and KEGG markers, higher AUC values are obtained. Furthermore, compared to the blood microbiome, the fecal microbiome shows a different community composition, whereas their changes in KEGG pathways are similar. Pathogenic bacteria Fusobacterium nucleatum ( F. nucleatum ) in feces increased gradually from the healthy group to the adenoma and CRC groups. Additionally, F. nucleatum in feces and blood shows a positive correlation in CRC patients. Cumulatively, the integration of blood microbiome and fragmentation pattern is promising for CRC diagnosis. IMPORTANCE The cell-free DNA of the human microbiome can enter the blood and can be used for cancer diagnosis, whereas its diagnostic potential in colorectal cancer and association with gut microbiome has not been explored. The microbial sequences in blood account for less than 1% of the total sequences. The blood microbial composition, KEGG functions, and fragmentation pattern are different among healthy individuals, adenoma patients, and CRC patients. Machine learning models based on these differential characteristics achieve high diagnostic accuracy, especially when they are integrated with fragmentation patterns. The great difference between fecal and blood microbiomes indicates that microbial sequences in blood may originate from various organs. Therefore, this study provides new insights into the community composition and functions of the blood microbiome of CRC and proposes an effective non-invasive diagnostic tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Lanzhou University, Lanzhou, Gansu, China.
- The Second Hospital of Lanzhou University, Lanzhou, China.
- The First Hospital of Lanzhou University, Lanzhou, China.
- The Third People's Hospital of Gansu Province, Lanzhou, China.
ORCID-Profile: Peng Chen
Förderung
- Gansu Provincial Science and Technology Major Project
- The Lanzhou Municipal Science and Technology Program
- The College Students' Innovation and Entrepreneurship Program of Lanzhou University, China
Zitieren
APA
Zhou, Z., Ma, Y., Zhang, D., Ji, R., Wang, Y., Zhao, J., Ma, C., Zhu, H., Shen, H., Jiang, X., Niu, Y., Lu, J., Zhang, B., Tu, L., Zhang, H., Ma, X., & Chen, P. (2025). Microbiome and fragmentation pattern of blood cell-free DNA and fecal metagenome enhance colorectal cancer micro-dysbiosis and diagnosis analysis: a proof-of-concept study. mSystems. https://doi.org/10.1128/msystems.00276-25
Vancouver
Zhou Z, Ma Y, Zhang D, Ji R, Wang Y, Zhao J, et al. Microbiome and fragmentation pattern of blood cell-free DNA and fecal metagenome enhance colorectal cancer micro-dysbiosis and diagnosis analysis: a proof-of-concept study. mSystems. 2025. doi:10.1128/msystems.00276-25
BibTeX
@article{Zhou2025,
author = {Zhou, Zhongkun and Ma, Yunhao and Zhang, Dekui and Ji, Rui and Wang, Yiqing and Zhao, Jianfang and Ma, Chi and Zhu, Hongmei and Shen, Haofei and Jiang, Xinrong and Niu, Yuqing and Lu, Juan and Zhang, Baizhuo and Tu, Lixue and Zhang, Hua and Ma, Xin and Chen, Peng},
title = {Microbiome and fragmentation pattern of blood cell-free DNA and fecal metagenome enhance colorectal cancer micro-dysbiosis and diagnosis analysis: a proof-of-concept study},
journal = {mSystems},
year = {2025},
doi = {10.1128/msystems.00276-25}
}
EUVIMED